Skip to main content

Summit Therapeutics Inc.

SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001599298

No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Summit Therapeutics Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SMMT: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4142+1
Shares8.46M3.18M−5.28M (−62.4%)
Value$8.46M$3.78M−$4.68M (−55.3%)

New holders (11)

Institutions that held Summit Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SMMT in Q3 2022
InstitutionSharesValue% of portfolio
Marshall Wace, LLP140,660$167.0K0.00%
Bank of Montreal28,500$35.0K0.00%
Group One Trading, L.P.24,714$29.0K0.00%
Northern Trust Corp22,903$27.0K0.00%
Jane Street Group, LLC20,259$24.0K0.00%
ProShare Advisors LLC16,925$20.0K0.00%
Two Sigma Securities, LLC17,092$20.0K0.00%
Man Group plc15,719$19.0K0.00%
Osterweis Capital Management Inc5,000$6.00K0.00%
China Universal Asset Management Co., Ltd.1,885$2.00K0.00%
BNP Paribas Arbitrage, SA1,159$1.38K0.00%

Sold out (10)

Institutions that held Summit Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of SMMT in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Polar Capital Holdings Plc5,599,407$5.60M
Alpine Global Management, LLC300,000$300.0K
Ergoteles LLC100,722$101.0K
Boothbay Fund Management, LLC81,559$82.0K
Citadel Advisors LLC56,743$57.0K
Renaissance Technologies LLC49,118$49.0K
Y-Intercept (Hong Kong) Ltd10,355$10.0K
New York State Common Retirement Fund217$0
Credit Suisse AG14$0
Simplex Trading, LLC63$0